Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
How heart failure risk rises after surgery
Wed June 29th - The development of atrial fibrillation following surgery is an important risk factor for heart failure, researchers report today. More
Brain surgery benefits intracranial pressure
Wed June 29th - Craniectomy for intracranial hypertension offers significant benefit, according to new guidance, triggered by British research. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
guide to breast disorders guide to womb disorders guide to menopause Complete Women's Health: from The Royal College of Obstetricians and Gynaecologists For books and family gift ideas click here
RSS graphic XML Graphic

Drugs hope to spare women breast surgery

Friday March 28th, 2014

Women with the breast cancer gene BRCA1 might be treated with drugs rather than surgery in the future, researchers say today.

The researchers in Belfast, UK, say they have found the first "credible" link between the gene and damage caused by high levels of the hormone oestrogen.

The gene is linked to breast and ovarian cancer while a range of treatments already exist for cancers linked to oestrogen.

Women with the gene have a very high risk of developing breast cancer - about 85% in their lifetime - leading to many, such as actress Angelina Jolie, choosing to have their breasts and ovaries removed.

The researchers at Queen's University, Belfast, say their discovery opens the way to prevent the disease with drugs rather than surgery.

They report their findings today in the journal Cancer Research.

The researchers say they hope to run clinical trials of the use of drug treatments for women with this gene.

Researcher Dr Kienan Savage said: “This discovery is very significant in the management of women with the BRCA1 gene mutation. It’s the first really credible evidence that oestrogen is driving cancer in women with a BRCA1 gene mutation.

"Because of this discovery, we now have the opportunity to propose an alternative treatment to surgery. It also opens up the possibility of pausing treatment for a period in order for women to have children, if desired.

“What also makes this exciting is that there are drugs already on the market which turn off oestrogen production. In theory, we could use these drugs to chemically reduce oestrogen production in women which could negate the need for irreversible surgery.”

Professor David Waugh, director of the university's Centre for Cancer Research, claimed the findings as a breakthrough.

He said: “This breakthrough by researchers at CCRCB is great news for women with the BRCA1 gene and the cancer research community as a whole. It is pivotal in that it reveals more about the mechanisms behind breast and ovarian cancer."

* A second study yesterday highlighted the changes in treatment that will emerge as high-speed genetic testing of women becomes common-place.

Reporting in the British Journal of Surgery, the researchers, from Norwich and Cambridge, UK, say improved gene testing may lead to women seeking to have more surgery than is usually offered when cancer is detected.

According to Dr Simon Pilgrim, women might choose a double mastectomy rather than a single one.

Cancer Research 28 March 2014

Opportunities and challenges of next-generation DNA sequencing for breast units. BJS 27 March 2014; doi:10.1002/bjs.9458 [abstract]

Tags: Cancer | Genetics | Pharmaceuticals | UK News | Women’s Health & Gynaecology

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)